Taro Pharmaceutical
在场
Taro Pharmaceutical 的所有者是 Sun Pharma.
是其中之一......
Sun Pharma 是一家在股票代码 SUNPHARMA (IN) 下上市的公司。
Sun Pharma 在 2 个国家有直接业务。Sun Pharma 拥有 4家子公司，其中包括 Chattem Chemicals、Natco Pharma 和 Sun Pharma USA。
他们在：
涉及Sun Pharma的并购和融资。
- Sun Pharma 已收购 Taro Pharmaceutical (公布2024六月25号).
- Sun Pharma has announced the acquisition of Taro Pharmaceutical (公布2024一月18号).
高管
查看带有其 23 名主要高管的组织结构图
Taro Pharmaceutical 搜索最多的简介
- Uday Baldota, Chief Executive Officer and Director
- James Kedrowski, Director
- Linda Benshoshan, Director
高管在Sun Pharma变化
- Tejash Chheda已作为General Manager and Head of Media加入公司 (新闻发布的2024九月24号).
- Sudhir Valia, Non-Independent Non-Executive Director, 将于 20248月1 退休 (新闻发布的2024七月16号).
- Sailesh Desai, Executive Director, 正在办理退休 (新闻发布的2024四月7号).
创建提醒
跟踪 Taro Pharmaceutical 的高管变动
药店
Sun Pharma 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Taro Pharmaceutical 的最新新闻稿
- Taro Provides Results for the Quarter Ended June 30, 2022 | Taro Pharmaceutical
- Taro to Release First Quarter Results on July 27, 2022 | Taro Pharmaceutical
- Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022 | Taro Pharmaceutical
- Taro Provides Results for the Year Ended March 31, 2022 | Taro Pharmaceutical
- News Releases | Taro Pharmaceutical
- Taro to Announce Full Year Results on May 26, 2022 | Taro Pharmaceutical
- Taro Completes Acquisition of Alchemee | Taro Pharmaceutical
- Taro to Acquire Alchemee From Galderma | Taro Pharmaceutical
- Taro Provides Results for December 31, 2021 | Taro Pharmaceutical
- Taro to Announce Third Quarter Results on January 27, 2022 | Taro Pharmaceutical
- View more press releases Close
通过电子邮件
